Goldman Sachs’s Adicet Bio ACET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.29M Sell
3,752,098
-64,458
-2% -$39.3K ﹤0.01% 3329
2025
Q1
$2.88M Buy
3,816,556
+63,691
+2% +$48.1K ﹤0.01% 3123
2024
Q4
$3.61M Sell
3,752,865
-7,132
-0.2% -$6.86K ﹤0.01% 3104
2024
Q3
$5.41M Sell
3,759,997
-523,375
-12% -$754K ﹤0.01% 2698
2024
Q2
$5.18M Buy
4,283,372
+277,785
+7% +$336K ﹤0.01% 2579
2024
Q1
$9.41M Buy
4,005,587
+3,976,974
+13,899% +$9.35M ﹤0.01% 2087
2023
Q4
$54.1K Sell
28,613
-30,898
-52% -$58.4K ﹤0.01% 4532
2023
Q3
$81.5K Sell
59,511
-10,478
-15% -$14.4K ﹤0.01% 4425
2023
Q2
$170K Sell
69,989
-29,317
-30% -$71.2K ﹤0.01% 4447
2023
Q1
$572K Sell
99,306
-188,921
-66% -$1.09M ﹤0.01% 4007
2022
Q4
$2.58M Sell
288,227
-106,854
-27% -$955K ﹤0.01% 3104
2022
Q3
$5.62M Buy
395,081
+49,534
+14% +$704K ﹤0.01% 2557
2022
Q2
$5.05M Buy
345,547
+117,516
+52% +$1.72M ﹤0.01% 2639
2022
Q1
$4.55M Buy
228,031
+64,406
+39% +$1.29M ﹤0.01% 2874
2021
Q4
$2.86M Buy
163,625
+125,609
+330% +$2.2M ﹤0.01% 3232
2021
Q3
$298K Buy
38,016
+22,451
+144% +$176K ﹤0.01% 4666
2021
Q2
$160K Sell
15,565
-30,190
-66% -$310K ﹤0.01% 5003
2021
Q1
$598K Buy
45,755
+35,515
+347% +$464K ﹤0.01% 4236
2020
Q4
$144K Buy
+10,240
New +$144K ﹤0.01% 4379
2020
Q3
Sell
-12,321
Closed -$185K 4410
2020
Q2
$185K Buy
12,321
+4,470
+57% +$67.1K ﹤0.01% 4006
2020
Q1
$56K Buy
7,851
+4,075
+108% +$29.1K ﹤0.01% 4255
2019
Q4
$39K Buy
3,776
+1,197
+46% +$12.4K ﹤0.01% 4217
2019
Q3
$160K Buy
2,579
+626
+32% +$38.8K ﹤0.01% 3968
2019
Q2
$139K Sell
1,953
-1,221
-38% -$86.9K ﹤0.01% 3949
2019
Q1
$152K Buy
3,174
+1,476
+87% +$70.7K ﹤0.01% 3949
2018
Q4
$102K Sell
1,698
-7,856
-82% -$472K ﹤0.01% 3883
2018
Q3
$1.01M Buy
+9,554
New +$1.01M ﹤0.01% 3191
2018
Q2
Sell
-1,518
Closed -$102K 4150
2018
Q1
$102K Buy
+1,518
New +$102K ﹤0.01% 4014